BIOSIMILAR

Aug. 20, 2019

Dr. Reddy’s Laboratories launched in India Versavo (bevacizumab), a biosimilar of Roche’s Avastin for the treatment of cancers.

About: 

  • Biosimilarity means that the biological product is highly similar to the reference product notwithstanding minor differences in clinically-inactive components. 

  • There are no clinically meaningful differences between the biological product and the reference product in terms of the safety, purity, and potency of the product. 

Source : The Hindu

Latest Current Affairs

See All